Increasing access to cost-effective therapies
Why partner with Glamzo?
are accessible through Glamzo Pharmaceutical Laboratory*
A product category with a promising future
For pharma manufacturers
A reliable partner to manufacturers committed to biosimilars
For providers
Easier access to emerging therapies to improve patient care
As a healthcare professional, you can help patients understand that biosimilars are safe and effective treatment options that offer them the same outcomes as their reference products at potentially lower out-of-pocket costs.
Understanding the difference between generics and biosimilars
Biosimilars are not generics. Generics are exact copies of synthetic pharmaceuticals and the active ingredients must be the same as a brand name drug. Biosimilars are copies of biologics, which are medications made with living cells. They can have slight differences in clinically inactive components. The important thing to remember is there is no difference in how a biosimilar and its reference product treats its indicated condition.
Increased biosimilar adoption can improve medication access and affordability — enabling us to better support the patients we serve. Below, find a list of biosimilars available through Glamzo Pharmaceutical Laboratory in the US.
